NCT01284660

Docosahexaenoic Acid (DHA) Effects on Cognitive Function, Craving and Psychosocial Factors in Heavy Cigarette Smokers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 51 (actual)
• Sponsor: Hillel Yaffe Medical Center · Other Government
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to assess effects of Docosahexaenoic Acid (DHA) as an add-on novel supplement on quality of life, cognitive function, craving and psychosocial factors in heavy cigarette smokers. In humans, no previous randomized, double blind controlled study has been conducted to evaluate these effects. The aim of the study is to 1. Test Docosahexaenoic Acid (DHA) beneficial effects on objective clinical indicators of cognitive function (choice reaction time, decision making, impulsivity, facial recognition) in smokers 2. Improvement of quality of life, cigarette craving, psychosocial factors and self-perceptions in smokers treated with DHA supplement

Conditions

• HEAVY TOBACCO SMOKERS

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	DHA	DHA ingested orally by heavy smokers
DIETARY_SUPPLEMENT	Oral ingestion of 5 placebo tablets	Oral ingestion of 5 tablets containing the following: gelatin,glycerine,water and soy oil made by the Solgar Pharmaceutical Co., Israel

Timeline

• Start date: 2011-11-01
• Primary completion: 2013-07-01
• Completion: 2013-09-01
• First posted: 2011-01-27
• Last updated: 2013-12-19

Locations

1 site across 1 country: Israel